ESMO in the Alps
The ESMO Congress 2025 will be the global stage for the exchange and debate of translational cancer science of excellence, first announcements of practice-changing data, and multidisciplinary must-have conversations set to spur transformative therapies against cancer.
ESMO in the Alps offers a unique opportunity to delve deeper into the presented findings. This event will include both a live meeting and a broadcasted webinar. The Scientific Committee will rigorously assess the outcomes and their implications for Swiss clinical practice. Engage with us as we explore the practice-changing content from ESMO. Participate in lively discussions and analyses of the latest data, connecting with experts from around the globe during the on-site session or easily join the conversation from the comfort of your home.
Steering commitee
- Prof. Dr. med. Jörg Beyer
- Dr. med. Daniel Helbling
Program
Preliminary Program
9:00 – 10:20 Lung Cancer
10:30 – 12:30 Breast & Gynecologic Cancer
12:30 – 13:45 Lunch
13:45 – 15:30 Genitourinary Cancer
15:45 – 16:30 Hot Topics
16:45 – 18:30 Gastrointestinal Cancer
Contact
Swiss Cancer Institute
Effingerstrasse 33
CH-3008 Berne
Tel: +41 31 389 91 91
events@swisscancerinstitute.ch
Sponsors
Platin Sponsor
-
AstraZeneca AG
Gold Sponsors
-
Bayer (Schweiz) AG
-
Eli Lilly (Suisse) SA
-
Pfizer Schweiz
-
Roche Pharma (Schweiz) AG
-
Takeda Pharma AG
Silver Spnsors
-
Amgen Switzerland AG
-
Astellas Pharma AG
-
Daiichi Sankyo (Schweiz) AG
-
JJ Johnson Johnson
-
Merck (Schweiz) AG
Bronze Sponsors
-
GSK GlaxoSmithKline AG
-
MSD Merck Sharp Dohme AG